Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Darou Pakhsh Pharma Chem (DPPCC) is a leading Iranian pharmaceutical company specializing in the production of Active Pharmaceutical Ingredients (APIs). Established as a subsidiary of the Tamin Pharmaceutical Investment Company (TPICO), it operates one of the largest API manufacturing facilities in the Middle East. The company's portfolio includes a wide range of essential substances such as acetaminophen, metformin, and various cardiovascular and respiratory agents. DPPCC serves both domestic and international markets, adhering to international GMP standards to ensure high-quality chemical synthesis. It plays a critical role in the Iranian healthcare supply chain by reducing reliance on imported raw materials.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Darou Pakhsh Pharma Chem.